急性妊娠脂肪肝

急性妊娠脂肪肝（ＡＦＬＰ）是妊娠末期发生的以肝细胞脂肪浸润、肝功能衰竭和肝性脑病为特征的疾病,　其发病率约为１／１３００００孕妇,孕妇及胎儿死亡率分别达３３．３％和６６．７％,预后较差,以初产妇和双胎妊娠多见,再次妊娠时少有复发倾向。１ 病因与发病机制ＡＦＬＰ的病因及发病机制尚未阐明,目前尚未见遗传因素与本病有关的报道,孕妇血清学检查和病毒培养阴性亦不支持感染因素致病的可能,大多数孕妇没有明确的毒物接触史。目前,多数人认为妊娠后体内性激素水平的变化与本病有直接关系,孕妇体内雌激素、生长激素、儿茶…     

妊娠急性脂肪肝研究新进展

妊娠急性脂肪肝（acute fatty liver of pregnancy,AFLP）是出现于妊娠晚期的一种严重罕见的并发症,曾称为＂妊娠特发性脂肪肝＂。其病理改变是肝细胞脂肪变性,导致临床上出现肝功能衰竭和肝性脑病,常伴有多脏器损害。目前,该病的发病机理尚不明确,至今仍无特效的治疗手段,     

双胎妊娠合并急性脂肪肝1例

双胎妊娠合并急性脂肪肝患者1例,以皮肤黏膜搔痒、消化道症状及黄疸为表现,起病急,病情重,及早终止妊娠是治疗AFLP的关键,诊断及时,治疗得当,预后良好.     

妊娠急性脂肪肝11例误诊原因分析

妊娠急性脂肪肝１１例误诊原因分析梁山县人民医院（２７２６００）牛月平，沈祥兰，刘敏我院１９８４～１９９５年将１１例妊娠急性脂肪肝误诊为其他疾病，现报告并分析如下。１误诊为妊娠合并急性病毒性肝炎３例举例：女，２５岁，妊娠３０周，因食欲不振、头痛、恶心、...     

妊娠急性脂肪肝4例临床病理分析

妊娠急性脂肪肝（AFLP）是一种罕见病,早期诊断、尽早终止妊娠显著改善预后。 例1,女性22岁,因孕1产0孕36”周、牙龈出血10d、加重伴黄疸5d急诊入院。入院前10d无明显诱因牙龈出血,能自行停止,近5d加重,血流不止,并出现全身黄疸,纳差,恶心、呕吐。无慢性肝炎、高血压病史。     

23例妊娠急性脂肪肝临床诊疗分析

目的探讨妊娠急性脂肪肝的早期诊断和治疗方法。方法对2004年1月至2014年10月在首都医科大学附属北京地坛医院分娩的23例妊娠急性脂肪肝(acute fatty liver of pregnancy,AFLP)患者的临床资料进行回顾性分析。根据胆红素分为2组:171μmol/L为重型组,≤171μmol/L为轻型组,对两组并发症例数进行统计比较。结果 23例妊娠急性脂肪肝患者均有明显消化道症状;实验室检查结果表明多数患者除胆红素升高及凝血功能障碍外,尿酸及乳酸脱氢酶存在异常升高;胆红素轻型组与胆红素重型组,发生肾功能不全,肺部感染及低蛋白血症的发病例数比较,P值分别为0.023,0.033和0.019,存在统计学意义,其他并发症P值介于0.071~1.000,无统计学意义。结论重视临床症状,结合实验室检查,尿酸及乳酸脱氢酶存在异常升高作为AFLP诊断的参考指标。一旦确诊AFLP后应积极终止妊娠,多学科综合支持治疗是抢救成功的关键。对于高胆红素的AFLP患者应尤其重视预防感染。     

妊娠急性脂肪肝与麻醉——13例临床分析

目的探讨妊娠急性脂肪肝（AFLP）的临床特点、围术期处理、母亲及围产儿结局,以便早期诊断和及时治疗,改善预后。方法对近3年我院收治的13例AFLP患者的症状、实验室检查、临床过程、围术期处理以及母亲和围产儿结局进行回顾性分析。结果AFLP76．92％发生于初产妇,男性胎儿占69．23％,前驱症状为乏力、纳差、恶心、呕吐、黄疸,实验室检查示凝血病、肝功能异常、低血糖、低蛋白血症、尿胆红素阴性,产妇死亡2例,占15．4％,无围产儿死亡。麻醉方法采用椎管内麻醉（10例,76．9％）,全身麻醉（2例,15．4％）。结论妊娠急性脂肪肝是发生于妊娠晚期的一种严重并发症,早期诊断、尽快终止妊娠和围术期积极的对症支持治疗是提高母儿预后的关键。麻醉方法应个体化,有明显凝血病的患者以全身麻醉首选。     

妊娠急性脂肪肝

妊娠急性脂肪肝(AFLP)是以妊娠第3周发生肝细胞脂肪浸润、肝功能衰竭及肝性脑病为特征的一种疾病,本清早在1934年由Stander和Gadden首次报道,于1940年Sheehan称产科急性黄色肝萎缩,后经Ober和Compter命名为妊娠急性脂肪肝。据测1966年AFLP的发病率为百万分之一,到1984年升到13328分之一,胎儿及孕妇的死亡率达85％,近期报告其死亡率分别降至23％及18％。至今国内报道14例,仅2例存活,发病率较西方国家低,但死亡率高达85.7％,     

The Initial Presentation of Fatty Liver of Pregnancy Mimicking Acute Viral Hepatitis

Acute fatty liver of pregnancy, a disease of the 3rd trimester of pregnancy, may have varied presentations. An unusual initial presentation of acute fatty liver of pregnancy mimicking an acute viral hepatitis is reported herein. Osmium tetroxide preparation of pathological specimen for the diagnosis of acute fatty liver of pregnancy is also discussed.     

Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update

The intricate relationship between metabolic-associated fatty liver disease (MAFLD) and maternal complications has rapidly become a significant health threat in pregnant women. The presence of MAFLD in pregnancy increases the maternal risk of metabolic complications and comorbidities for both mother and baby. The preexistence or development of MAFLD in pregnancy is a complex multifactorial disorder that can lead to further complications for mother and baby. Therefore, as pregnant women are severely underrepresented in clinical research, there is a great need for a fair inclusion of this group in clinical trials. This review aims to explore the effects of MAFLD during pregnancy in the context of maternal complications and outcomes and explore the effects of pregnancy on the development and progression of MAFLD within the context of maternal obesity, altered metabolic profiles, gestational diabetes and altered hormonal profiles. We also addressed potential implications for the presence of MAFLD during pregnancy and its management in the clinical setting.     

Study of the Liver Changes Occurring in Preeclampsia and Their Possible Pathogenetic Connection with Acute Fatty Liver of Pregnancy

Objective: The objective of the present study was to investigate liver involvement in preeclampsia on the basis of clinical, laboratory, and histological data and to detect a possible connection with fatty liver of pregnancy by the determination of microvesicular fatty infiltration of the liver. Methods: The authors studied the liver changes in 10 patients with preeclampsia, observing the clinical and laboratory alterations, the macroscopic liver surface features by laparoscopy, and the presence of microvesicular fatty infiltration by specific lipid staining of hepatic tissue collected by needle biopsy. Results: Macroscopy of the liver surface disclosed some degree of subcapsular liver hemorrhage in all cases; however, the hemorrhage was not related to the clinical and histological severity of the disease. Microvesicular fat droplets were observed in all patients, and the intensity of the fat deposition was not related to pressor levels, laboratory alterations, or the evolution of preeclampsia. Conclusions: The presence of fatty liver infiltration in all patients studied supports the idea that preeclampsia and acute fatty liver of pregnancy could be components of the same pathologic spectrum, with a probable, but still unproved, pathogenetic connection. The deficiency of the long chain 3-hydroxyacyl-coenzyme A dehydrogenase activity may be the determining factor in the evolution of the disease.     

脂肪肝与胰岛素抗性的关系

目的探讨脂肪肝与胰岛素抗性的关系。方法对30例诊断为脂肪肝患者的临床资料作回顾性分析。结果多数患者合并胰岛素抗性综合征(高血压、肥胖症、糖尿病、高脂血症),18例接受口服葡萄糖耐量试验(OGTT)患者中,1例确诊为2型糖尿病,17例患者中3例空腹血糖减损(IFG),1例糖耐量减退(IGT)及13例糖耐量正常(NGT)具有较正常人为高的血浆胰岛素(INS)浓度,胰岛素抗性指数为8.91±1.52%。结论脂肪肝与胰岛素抗性所致的代谢紊乱关系紧密,呈正相关关系。